Trials / Unknown
UnknownNCT04220450
T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- Dr. Andreas Kammerlander · Academic / Other
- Sex
- All
- Age
- 18 Months
- Healthy volunteers
- —
Summary
On clinically indicated Cardiovascular Magnetic Resonance studies, native T1-times and extracellular volume of the liver will be assessed and findings correlated with established risk calculators for non-alcoholic fatty liver disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | T1 mapping on Cardiovascular Magnetic Resonance Studies | On clinically indicated Cardiovascular Magnetic Resonance Imaging Studies, native T1-times and extracellular volume will be determined |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2021-06-01
- Completion
- 2021-06-15
- First posted
- 2020-01-07
- Last updated
- 2020-01-07
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04220450. Inclusion in this directory is not an endorsement.